TIGR4

TIGR4, also known as T-cell immunoglobulin and mucin domain containing 4, is a protein that in humans is encoded by the TIGIT gene. This gene is located on the short arm of chromosome 11 (11p15.5). TIGIT is a member of the immunoglobulin superfamily and is primarily expressed on the surface of regulatory T cells (Tregs).

The TIGIT protein plays a crucial role in immune regulation. It interacts with the B7 family member B7-H1 (CD80) on antigen-presenting cells (APCs) and the B7 family member B7-DC (CD86) on dendritic cells (DCs). This interaction is essential for the activation and function of Tregs, which are critical for maintaining immune tolerance and preventing autoimmune diseases.

TIGIT also interacts with the co-stimulatory molecule CD40 on APCs. This interaction can enhance the activation of Tregs and promote their suppressive function. Additionally, TIGIT can interact with the co-stimulatory molecule OX40 on APCs, which can further enhance Treg activation and function.

TIGIT expression is regulated by various factors, including cytokines and transcription factors. For example, the transcription factor Foxp3 is essential for the development and function of Tregs, and it regulates the expression of TIGIT in these cells.

Mutations in the TIGIT gene have been associated with various immune-related disorders, including autoimmune diseases and inflammatory conditions. For example, loss-of-function mutations in TIGIT have been linked to autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), while gain-of-function mutations have been associated with inflammatory bowel disease (IBD) and psoriasis.

In summary, TIGIT is a key player in immune regulation, particularly in the activation and function of Tregs. Its interactions with various co-stimulatory molecules on APCs are essential for maintaining immune tolerance and preventing autoimmune diseases. Further research is needed to fully understand the complex roles of TIGIT in immune regulation and its potential as a therapeutic target for immune-related disorders.